04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
On December 20, 2019, federal legislation approving spending limits for the 2020 fiscal year was sig...
Read More >
Compliance officers and general counsel at corporations and businesses are told to surveil the lands...
Read More >
The Massachusetts Department of Family and Medical Leave (“DFML”) has posted the much-anticipated ...
Read More >
The Pennsylvania Supreme Court upheld the Pittsburgh Paid Sick Days Act (“PSDA”) in a decision tod...
Read More >
In December 2019, the Colorado Department of Labor and Employment, Division of Labor Standards and S...
Read More >
On August 8, 2019, the Minneapolis City Council joined the state of Minnesota in requiring wage noti...
Read More >